Cytomos is developing a novel unbiased, single-cell resolution analysis method capable of providing unprecedented information on cells in suspension. Cytomos Dielectric Spectroscopy (CDS) technology provides a new high content analytical tool for assessing unique, intrinsic cellular characteristics with the potential to offer a disruptive method for improving process monitoring during cell therapy manufacturing processes